Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis. - Wikidata - wikimedia - TriplyDB

Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.

Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.

http://www.wikidata.org/entity/Q46937067

about

The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects Improved method for the quantification of lysophospholipids including enol ether species by liquid chromatography-tandem mass spectrometry.Mass spectrometry methodology in lipid analysis.Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities Serum metabolomics analysis reveals changes in signaling lipids in breast cancer patients.Plasma levels of lysophosphatidic acid in ovarian cancer versus controls: a meta-analysis.Chemical evolution of autotaxin inhibitors The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer.Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.A Cleanup Method for Mass Spectrometric Analysis of Sphingosine- and Ceramide-1-Phosphate in Blood and Solid Tissue Using a Phosphate Capture Molecule.Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulation.Roles of lysophosphatidic acid in cardiovascular physiology and disease ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.Characterization of lysophosphatidic acid subspecies produced by autotaxin using a modified HPLC ESI-MS/MS method.Lipidomics by ultrahigh performance liquid chromatography-high resolution mass spectrometry and its application to complex biological samples.Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences.The metabolomics and lipidomics window into thyroid cancer research.Biogenesis, transport and remodeling of lysophospholipids in Gram-negative bacteria.Autotaxin inhibitors: a patent review (2012-2016).An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples.A rapid and quantitative LC-MS/MS method to profile sphingolipids.Reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: Its possible protective role in renal fibrosis Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine.Structural elucidation of molecular species of pacific oyster ether amino phospholipids by normal-phase liquid chromatography/negative-ion electrospray ionization and quadrupole/multiple-stage linear ion-trap mass spectrometry.Challenges in accurate quantitation of lysophosphatidic acids in human biofluids Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.Roles of LPA receptor signaling in breast cancer.Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients

P2860

Q28388695-ECD12194-E893-40D6-9EF1-04CE72B3B674 Q33577898-7719FC30-EA42-45B4-896B-3227AAA15610 Q33907807-E0775ADC-8DB2-4B31-AEF4-934B36E263C3 Q34359284-416AA96F-43A9-4036-AACF-CA3170A4CC4E Q35185640-6773CBE3-F808-4760-B4DD-FB8A75F8F7B0 Q35693105-AA971C82-902E-468A-BE93-6D1AD45FE738 Q35848103-5793641F-EFD6-4D78-8C7E-FFB0ADB9DA81 Q35949924-C7D64F33-F460-446E-80A8-F89D5AF596C4 Q35978114-01FBBC30-77BC-405C-B133-BFC5A93E077C Q36028380-A435DEE4-C3FD-4D8E-AE84-71E79432A539 Q36165662-86AF7E72-A7D5-4393-9852-6E1F873AED1B Q36329238-F818F366-7F6E-4174-94AB-A6CBC6936F65 Q36932111-2228521C-9725-4332-964A-33173D4016D3 Q36948520-AB22EA77-E24A-46E5-8375-23435D3B00F0 Q37390177-A6168730-2973-476B-B7EE-E7F77792745B Q37640820-E89E6607-BE78-4713-83B0-1FD938D4699C Q38707392-BD151703-C717-485A-8DDA-1CA4C2AE3373 Q38803730-927EA83A-2E23-4003-AB6B-6F1AFBC05A2B Q38996666-FAD8B95C-3F19-4933-8F98-34B07001FE0E Q39036706-2AA773DE-6B45-45AB-AD40-86BC3DFEE06C Q39266426-CC1E89C8-4E14-41ED-B27D-67DF3D349BA2 Q39794698-63309A48-8C09-4B77-AF1E-FA3C330E715A Q40948476-5D5CA420-A60F-4F89-A3DE-F29DE4C263F1 Q41680429-93418C26-4C85-4C5F-8732-EF5B3B8F49F8 Q41818510-C617A887-EDA6-4E67-86F7-19D7B30F325F Q42205596-A41018B2-4AFC-4B0D-9DF8-49D267DA1F71 Q42747131-D0248168-F750-49F9-8B16-393CDB28BCD4 Q48268746-F4DB4B95-BD14-414A-BFDA-D5D738561E1A Q51489523-3CD614D6-D988-48B0-9397-E49291DEEDFA Q57924377-E5E337B6-8F91-497B-A4D8-9CB91440EA15

P2860

Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.

http://www.wikidata.org/entity/Q46937067

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Liquid chromatography mass spe ...... omarkers for cancer diagnosis.

@en

Liquid chromatography mass spe ...... omarkers for cancer diagnosis.

@nl

type

label

Liquid chromatography mass spe ...... omarkers for cancer diagnosis.

@en

Liquid chromatography mass spe ...... omarkers for cancer diagnosis.

@nl

prefLabel

Liquid chromatography mass spe ...... omarkers for cancer diagnosis.

@en

Liquid chromatography mass spe ...... omarkers for cancer diagnosis.

@nl

P1433

Q46937067-3CA7F284-A567-46B7-AA33-32840F6C462A

P1476

Q46937067-0113D858-1C25-4404-BF77-40AA446F8204

P2093

Q46937067-01A0DAEA-1ABC-4045-BB2C-951453112161

Q46937067-057B701A-5981-47D7-A990-79F1C85D9798

Q46937067-55159ECA-8531-48A4-9BEF-09537E112F30

Q46937067-6AAD0DA0-27EF-4898-96C4-CF92D1A668B4

Q46937067-6E7A26ED-D957-486C-B7AC-012DCA0538C2

Q46937067-86B4999B-09E5-4F27-8A47-E63A200D88DA

Q46937067-957FC5D3-48AD-469B-A2BD-B03D6D2B16B3

Q46937067-9BBBFF25-2D26-4857-BC85-05C8BB823530

Q46937067-DC818268-1CD5-4FD8-9131-74454C7BD61C

P304

Q46937067-9841966A-C28A-48F7-9B8E-0C335D3B2801

P31

Q46937067-166F325D-458B-4B93-839D-F8EC50A8C671

P356

Q46937067-097C7A7E-0948-43CB-BEEC-E3F1CCF4921C

P407

Q46937067-3A86C9E2-BFAC-4ADD-A793-CCA7313EF9A6

P478

Q46937067-76AD6984-143D-41FD-8D72-80B783ED2212

P577

Q46937067-8EB12438-F1D7-4F63-845D-F44DCEF0E371

P698

Q46937067-DAAEB519-2AE6-41C9-A1F4-E8ADEA6E2CFF

P356

S0076-6879(07)33001-2

P1433

Methods in Enzymology

P1476

Liquid chromatography mass spe ...... omarkers for cancer diagnosis.

@en

P2093

Andrew K Godwin

http://www.w3.org/2001/XMLSchema#string

Edward Felix

http://www.w3.org/2001/XMLSchema#string

Gordon Mills

http://www.w3.org/2001/XMLSchema#string

Jihai Pang

http://www.w3.org/2001/XMLSchema#string

Mandi Murph

http://www.w3.org/2001/XMLSchema#string

Robert Newman

http://www.w3.org/2001/XMLSchema#string

Rosanne Trost

http://www.w3.org/2001/XMLSchema#string

Shuying Liu

http://www.w3.org/2001/XMLSchema#string

Tamotsu Tanaka

http://www.w3.org/2001/XMLSchema#string

P304

1-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0076-6879(07)33001-2

http://www.w3.org/2001/XMLSchema#string

P407

P478

433

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17954226

http://www.w3.org/2001/XMLSchema#string